Experimental estimate · v0.11

DR Congo: Bundibugyo Ebola outbreak

Democratic Republic of the CongoThrough 7 Sep 2026

Report prepared 8 October 2026

Estimated USU0.24 million

Acute illness, including fatal cases

Reported deaths3,267

Confirmed-case population. Source context

Cases modeled6,757

confirmed cases

1 USU is the modeled burden of one specified six-hour kidney-stone pain reference. It is a common reporting unit, not a claim that the experiences feel the same.

Approximate, assumption-based USU for the included experience. Deaths are a separate measure. Includes fatal illness.

What this estimate tells us

About 244 thousand USU is assigned to the 6,757 confirmed cases in this snapshot. The estimate combines ordinary illness allowances for 3,490 other reported cases with complete fatal illness courses for 3,267 reported deaths. This models suffering before death. It does not assign a value to death itself or to lost life years.

From one modeled experience to the total

Cases in the reported total
6,757
Modeled average per case
≈ 36.0 USU
Estimated total
≈ 244 thousand USU

Population count × modeled average ≈ total USU

This is a modeled average across the included cases. Other reported cases are assigned about 35.6 USU each; reported fatal cases are assigned about 36.6 USU each. Each course is weighted by its case count. The average can differ between outbreaks because the reported mix of cases differs, even when the same course assumptions are used. See the two courses and their assumed durations →

This is an assumption-based average, not an observed average or a prediction for any individual. Figures shown here are rounded; calculations use unrounded values. How to read these averages.

This template draws on small studies of earlier Bundibugyo-virus outbreaks. It does not use patient-level duration or pain measurements from the 2026 outbreak. Persistent symptoms after the acute illness are unestimated.

Two groups, one course per case

6,757 confirmed cases = 3,490 other reported cases + 3,267 reported fatal cases. “Other” includes unresolved outcomes and does not mean known survivors or mild cases.

Other reported cases

3,490 cases

14 days × average intensity 5

3,490 × 14 × 24 × 5 ÷ 47.25

≈ 35.6 USU per case

Estimated total for this group: about 124 thousand USU.

Reported fatal cases

3,267 cases

12 days × average intensity 6

3,267 × 12 × 24 × 6 ÷ 47.25

≈ 36.6 USU per case

Estimated total for this group: about 119 thousand USU.

Combined estimateAbout 244 thousand USU

Rounded for readability. The downloadable inputs retain the calculation precision.

The fatal course replaces the ordinary allowance for those same cases. It covers the complete illness ending at death, so there is no additional terminal-period charge. Death itself, lost life years and bereavement are not assigned USU.

Intensity is a combined 0–10 average over the elapsed course, including relief, sleep and intervals without experience. No intensity is assigned after death or to known absence of experience. Why divide by 47.25?

Why these durations and intensities?

Bundibugyo Ebola: other reported cases

The original all-case assumption of 14 days is retained for cases not reported dead at the cutoff. Historical series reported courses around 9-10 days in Uganda and 15-18 days in Isiro. Fourteen days is a rounded choice, not a pooled mean, a survivor-specific estimate or an observed 2026 average. Unresolved cases remain in this group; no future deaths are imputed. [S14] [S15]

The studies describe headache, muscle and abdominal pain, gastrointestinal symptoms and marked weakness. We assign intensity 5 as a provisional combined whole-day average, allowing for treatment, relief and sleep. Neither study measured USU intensity. Choosing 5 rather than the dengue value 3 or chikungunya value 4 is a model judgment, not a demonstrated clinical ratio. [S14] [S15]

Bundibugyo Ebola: fatal illness

We select 12 days between the historical median onset-to-death durations of 9 days in Uganda and 15 days in Isiro. It represents the complete symptomatic course ending at death, not an extra terminal period. It is not a pooled mean or an observed 2026 average; the studies were small and treatment settings differed. [S14] [S15]

We assign intensity 6 as a combined time-average of pain and other acute distress over the whole fatal course, including relief, sleep and intervals without experience. This is a provisional judgment above the existing value 5, not a measured USU mapping. Concurrent symptoms are represented together and are not added again. No intensity is assigned after death or to known absence of experience. [S14] [S15]

What changed in version 0.4?

Version 0.3 assigned the same 14-day, intensity-5 course to all 6,757 cases: 240,248.89 USU. The revised estimate is 243,567.75 USU, a change of +3,318.86 USU (+1.381%).

For the 3,267 reported fatal cases, 116,160.00 USU is removed and replaced with 119,478.86 USU. The reference unit and source counts are unchanged.

What changes the estimate?

Under the central assumptions, other reported cases contribute 50.9%; reported fatal cases contribute 49.1% of the total. Both courses are varied below.

Each row uses the same reported counts and included experiences. The lower and higher rows change duration and intensity together for every included course.

Illustrative scenarios for the whole estimate
ScenarioAssumed coursesEstimated USU
Lower assumptionsOther reported cases: 7 days at intensity 3
Reported fatal cases: 9 days at intensity 5
112 thousand
Central assumptionsOther reported cases: 14 days at intensity 5
Reported fatal cases: 12 days at intensity 6
244 thousand
Higher assumptionsOther reported cases: 21 days at intensity 7
Reported fatal cases: 15 days at intensity 7
435 thousand

These are alternative assumptions, not confidence intervals or bounds. Counts can be incomplete or misclassified; omitted experiences and the validity of the intensity scale remain outside this calculation. Actual burden could fall outside these examples.

Change one assumption at a time

Only the named input changes. Every other duration, intensity and count stays at its central value. Each result is the total for the whole report.

Effect of individual inputs
Input variedLower input and resulting totalHigher input and resulting total
Other reported cases
Duration
7 days
182 thousand USU
21 days
306 thousand USU
Other reported cases
Average intensity
3 / 10
194 thousand USU
7 / 10
293 thousand USU
Reported fatal cases
Duration
9 days
214 thousand USU
15 days
273 thousand USU
Reported fatal cases
Average intensity
5 / 10
224 thousand USU
7 / 10
263 thousand USU

Fatal illness remains a replacement course for the same reported fatal cases; no case is counted twice. How the scenarios are chosen.

Download scenario calculations (CSV) · Reproduce the scenarios (Python)

What goes into this number?

Included

One complete acute illness course per confirmed case, combining pain, gastrointestinal symptoms and other acute distress. The 3,267 cases reported dead receive a 12-day, intensity-6 fatal course; the other 3,490 cases retain the 14-day, intensity-5 assumption. These are disjoint groups, not extra cases. Other reported cases include unresolved outcomes and are not all known survivors.

Source population and period

WHO reported 6,757 confirmed cases in DR Congo through 7 September 2026, including two cases diagnosed there and subsequently treated in Germany. We retain WHO’s country attribution. Cases reported in Uganda and France, contacts under monitoring, and suspected or unreported cases are excluded. This is a cumulative outbreak snapshot, not the number currently ill. Some outcomes were still unresolved at the cutoff. [S13]

Outside this estimate

Incubation without symptoms, persistent post-Ebola symptoms, caregiver distress, bereavement, unconfirmed or unreported illness, and post-death loss. Individual severity and time to death or recovery are not reconstructed.

Omitted experiences are unestimated, not known to be zero. This is not a complete event total or a guaranteed lower bound.

Whole representative courses are assigned to the source-defined cases or cohort. Course time can extend beyond the reporting dates. The fatal course ends at death; individual symptom histories and timing are not reconstructed. Other cases include unresolved outcomes, and no future deaths are imputed. No causal baseline or suffering after death is assigned.

Mortality source context

WHO reported 3,267 deaths among the 6,757 confirmed cases attributed to DR Congo through 7 September 2026. These deaths identify the cases assigned a fatal illness course. They are removed from the ordinary group and are not added as extra cases. The mortality count remains visible as a separate measure. [S13]

Suffering before death: included

A complete fatal illness course is included for 3,267 source-defined fatal cases. It replaces their ordinary allowance; each case receives one course. This does not cover every possible death or consequence.

See the two-group calculation →

Why this death count fits the calculation: WHO identifies the 3,267 deaths within the same 6,757 confirmed cases attributed to DR Congo through 7 September 2026. [S13]

USU estimates experienced suffering during lived time. Death itself and lost life years are not assigned USU. A report can use a death count to identify a distinct course of suffering before death, as in the disease fatal-course calculations. Bereavement remains unestimated.

Sources and calculation data

Related reading

How suffering before death is included

Search WSI